Hims & Hers Health, Inc. has completed its acquisition of Eucalyptus, a digital health company, significantly expanding its international footprint and advancing its goal of becoming a leading global consumer health platform. To facilitate the transaction, the company amended its existing credit agreement.
Key Details
- Acquisition: The company completed its previously announced acquisition of EUC Management Pty Ltd (d/b/a Eucalyptus) on June 2, 2026.
- Strategic Impact: The acquisition extends Hims & Hers' presence into key international markets, including Australia, Canada, Germany, Japan, and the United Kingdom.
- Credit Agreement Amendment: On May 29, 2026, the company entered into an amendment to its Revolving Credit and Guaranty Agreement to facilitate the acquisition, which included increasing downstream investment capacity and providing a grace period for covenant compliance.
- Financial Outlook: Management stated this global expansion reinforces confidence in its long-term targets of $6.5 billion in revenue and $1.3 billion in Adjusted EBITDA by 2030.